Investing Profile

Brendan Bulik-Sullivan

VCInvestor
Partner at GV
gv.com/team/brendan-bulik-sul...San Francisco, California
Photo of Brendan Bulik-Sullivan, Partner at GV (Google Ventures)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$250K - $50.0M
$25.0M
16
$8B
CompanyStageDateRound SizeTotal Raised
Metsera
Series BNov 2024$220M
Series AApr 2024$290M
$510M
Co-investors: Kristina Burow (ARCH Venture Partners), Paul Berns (ARCH Venture Partners), Nimish Shah (Venrock)
Santa Ana Bio
Series BJun 2024$130M
Series AFeb 2023$43M
$170M
Co-investors: Vineeta Agarwala (Andreessen Horowitz), Peter Emtage (Versant Ventures), Jerel Davis (Versant Ventures), Shinichiro Fuse
Areteia Therapeutics
Series AFeb 2024$75M
Series AJul 2022$350M
$430M
Co-investors: Paul Berns (ARCH Venture Partners), Adam Koppel (Bain Capital Life Sciences)
Comanche Biopharma
Series BJan 2024$75M
Series AMay 2023$36M
$110M
Co-investors: Scott Gottlieb (New Enterprise Associates (NEA)), David Grayzel (Atlas Venture)
Bitterroot Bio
Series AJun 2023$150M
$150M
Co-investors: Anthony Philippakis (GV (Google Ventures)), Steven Gillis (ARCH Venture Partners), Andrew ElBardissi (Deerfield Management)
Ventus Therapeutics
Series CFeb 2022$140M
Series BApr 2021$100M
Series AMay 2020$60M
$300M
Co-investors: Jerel Davis (Versant Ventures)
Sonoma Biotherapeutics
Series BAug 2021$270M
$340M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Robert Nelsen (ARCH Venture Partners)
Taysha Gene Therapies
Series BAug 2020$95M
$95M
Co-investors: David Schenkein (GV (Google Ventures))